October 2018 marks the 10th anniversary of TrialX Inc. and Applied Informatics Inc. Our journey officially began on 12th October, 2008, after we were approached by Google mentioning that they liked our hack for trial search…
Without clinical trials we cannot expect to see any advancements in medicine; and to participate in one, patients need to be aware of ongoing trials. The National Cancer Institute (NCI) HINTS (Health Information Trends Survey, hints.cancer.gov)…
We are excited to announce that last month our online patient-recruitment platform iConnect 2.0 went live with CenterWatch. Clinical trials professionals as well as patients trust CenterWatch to get any information related to clinical trials. It…
Two radically new gene based immunotherapies were approved by the FDA this year – Kymriah followed by Yescarta – in August and October, respectively. Approved in August 2017, before Novartis named the drug Kymriah (Tisagenlecleucel) – it…
TrialX is excited to participate and present in AMIA 2017, the 41st anniversary of the annual symposia conducted by the American Medical Informatics Association (AMIA). Every year, leading informaticians such as – translational scientists, clinicians,…
iConnect 2.0 is a specifically designed online platform that facilitates patient-recruitment for academic medical centers, sponsors, and patient advocacy groups. iConnect 2.0 helps overcome challenges of patient recruitment in clinical trials by: Creating a…
TrialX team had an exhilarating day on day1 of #DIA2017. Our CEO Sharib Khan, CTO Chintan Patel, creative director Aziz Rawat, and VP Clinical Trial Solutions Robert Ryan spent the day presenting our #patientengagement #patientrecruitment and…